Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
Clinical trial NCT03130439 · TERMINATED
Trial details
- NCT number
- NCT03130439
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-26
- Primary completion
- 2021-08-18
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.